{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T08:26:52Z","timestamp":1751012812965},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,9]]},"DOI":"10.7759\/cureus.48591","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T07:42:51Z","timestamp":1699602171000},"source":"Crossref","is-referenced-by-count":1,"title":["Development of Asthma-Like Symptoms After COVID-19: A Cross-Sectional Study in Dubai, United Arab Emirates"],"prefix":"10.7759","author":[{"given":"Syed Arshad","family":"Husain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirarshia","family":"Rategh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Omar","family":"Larik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon G","family":"D'Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Mary","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassam","family":"Mahboub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu B","year":"2021","unstructured":"Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021, 19:141-54. 10.1038\/s41579-020-00459-7","journal-title":"Nat Rev Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui J","year":"2019","unstructured":"Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019, 17:181-92. 10.1038\/s41579-018-0118-9","journal-title":"Nat Rev Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.02.010","article-title":"Coronavirus 2019-nCoV: A brief perspective from the front line","volume":"80","author":"Han Q","year":"2020","unstructured":"Han Q, Lin Q, Jin S, You L. Coronavirus 2019-nCoV: A brief perspective from the front line. J Infect. 2020, 80:373-7. 10.1016\/j.jinf.2020.02.010","journal-title":"J Infect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233147","article-title":"Prevalence, severity and mortality associated with COPD and smoking in patients with COVID- 19: A rapid systematic review and meta-analysis","volume":"15","author":"Alqahtani JS","year":"2020","unstructured":"Alqahtani JS, Oyelade T, Aldhahir AM, et al.. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID- 19: A rapid systematic review and meta-analysis. PLoS One. 2020, 15:e0233147. 10.1371\/journal.pone.0233147","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00547-2020","article-title":"Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis","volume":"55","author":"Guan WJ","year":"2020","unstructured":"Guan WJ, Liang WH, Zhao Y, et al.. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. Eur Respir J. 2020, 55:2000547. 10.1183\/13993003.00547-2020","journal-title":"Eur Respir J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann M","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, et al.. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020, 181:271-280.e8. 10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00688-2020","article-title":"ACE-2 expression in the small airway epithelia of smokers and COPD patients: Implications for COVID-19","volume":"55","author":"Leung JM","year":"2020","unstructured":"Leung JM, Yang CX, Tam A, et al.. ACE-2 expression in the small airway epithelia of smokers and COPD patients: Implications for COVID-19. Eur Respir J. 2020, 55:2000688. 10.1183\/13993003.00688-2020","journal-title":"Eur Respir J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01261-2020","article-title":"COVID-19 and nicotine as a mediator of ACE-2","volume":"55","author":"Leung JM","year":"2020","unstructured":"Leung JM, Yang CX, Sin DD. COVID-19 and nicotine as a mediator of ACE-2. Eur Respir J. 2020, 55:2001261. 10.1183\/13993003.01261-2020","journal-title":"Eur Respir J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: Interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik RA","year":"2011","unstructured":"Dweik RA, Boggs PB, Erzurum SC, et al.. An official ATS clinical practice guideline: Interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011, 184:602-15. 10.1164\/rccm.9120-11ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2016.07.010","article-title":"Eosinophilia","volume":"43","author":"Kovalszki A","year":"2016","unstructured":"Kovalszki A, Weller PF. Eosinophilia. Prim Care. 2016, 43:607-17. 10.1016\/j.pop.2016.07.010","journal-title":"Prim Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61221-5","article-title":"Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma","volume":"95","author":"Borish L","year":"2005","unstructured":"Borish L, Chipps B, Deniz Y, Gujrathi S, Zheng B, Dolan CM. Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2005, 95:247-53. 10.1016\/S1081-1206(10)61221-5","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref12","unstructured":"A healthy lifestyle - WHO recommendations. (2010). Accessed. July 25, 2023: https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/a-healthy-lifestyle---who-recommendations."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.10.049","article-title":"Impact of allergic rhinitis and asthma on COVID-19 infection, hospitalization, and mortality","volume":"10","author":"Ren J","year":"2022","unstructured":"Ren J, Pang W, Luo Y, et al.. Impact of allergic rhinitis and asthma on COVID-19 infection, hospitalization, and mortality. J Allergy Clin Immunol Pract. 2022, 10:124-33. 10.1016\/j.jaip.2021.10.049","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: A cohort study","volume":"397","author":"Huang C","year":"2021","unstructured":"Huang C, Huang L, Wang Y, et al.. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021, 397:220-32. 10.1016\/S0140-6736(20)32656-8","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian A","year":"2021","unstructured":"Nalbandian A, Sehgal K, Gupta A, et al.. Post-acute COVID-19 syndrome. Nat Med. 2021, 27:601-15. 10.1038\/s41591-021-01283-z","journal-title":"Nat Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.221806","article-title":"Long-term lung abnormalities associated with COVID-19 pneumonia","volume":"306","author":"Kanne JP","year":"2023","unstructured":"Kanne JP, Little BP, Schulte JJ, Haramati A, Haramati LB. Long-term lung abnormalities associated with COVID-19 pneumonia. Radiology. 2023, 306:e221806. 10.1148\/radiol.221806","journal-title":"Radiology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07252-2","article-title":"Persistent cough and asthma-like symptoms post COVID-19 hospitalization in children","volume":"22","author":"Esmaeilzadeh H","year":"2022","unstructured":"Esmaeilzadeh H, Sanaei Dashti A, Mortazavi N, Fatemian H, Vali M. Persistent cough and asthma-like symptoms post COVID-19 hospitalization in children. BMC Infect Dis. 2022, 22:244. 10.1186\/s12879-022-07252-2","journal-title":"BMC Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.niox.2022.05.002","article-title":"Fractional exhaled nitric oxide (FeNO) level as a predictor of COVID-19 disease severity","volume":"124","author":"Lior Y","year":"2022","unstructured":"Lior Y, Yatzkan N, Brami I, et al.. Fractional exhaled nitric oxide (FeNO) level as a predictor of COVID-19 disease severity. Nitric Oxide. 2022, 124:68-73. 10.1016\/j.niox.2022.05.002","journal-title":"Nitric Oxide"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2021.02.021","article-title":"The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection","volume":"127","author":"Ho KS","year":"2021","unstructured":"Ho KS, Howell D, Rogers L, Narasimhan B, Verma H, Steiger D. The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection. Ann Allergy Asthma Immunol. 2021, 127:42-8. 10.1016\/j.anai.2021.02.021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237960","article-title":"Prognostic factors in Spanish COVID-19 patients: A case series from Barcelona","volume":"15","author":"Sis\u00f3-Almirall A","year":"2020","unstructured":"Sis\u00f3-Almirall A, Kostov B, Mas-Heredia M, et al.. Prognostic factors in Spanish COVID-19 patients: A case series from Barcelona. PLoS One. 2020, 15:e0237960. 10.1371\/journal.pone.0237960","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015125","article-title":"Inhaled corticosteroids for the treatment of COVID-19","volume":"3","author":"Griesel M","year":"2022","unstructured":"Griesel M, Wagner C, Mikolajewska A, et al.. Inhaled corticosteroids for the treatment of COVID-19. Cochrane Database Syst Rev. 2022, 3:CD015125. 10.1002\/14651858.CD015125","journal-title":"Cochrane Database Syst Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33311-1","article-title":"Asthma","volume":"24","author":"Papi A","year":"2018","unstructured":"Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018, 24:783-800. 10.1016\/S0140-6736(17)33311-1","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4997\/JRCPE.2020.409","article-title":"Retrospective studies - utility and caveats","volume":"50","author":"Talari K","year":"2020","unstructured":"Talari K, Goyal M. Retrospective studies - utility and caveats. J R Coll Physicians Edinb. 2020, 50:398-402. 10.4997\/JRCPE.2020.409","journal-title":"J R Coll Physicians Edinb"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/204616-development-of-asthma-like-symptoms-after-covid-19-a-cross-sectional-study-in-dubai-united-arab-emirates","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:58Z","timestamp":1707509458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/204616-development-of-asthma-like-symptoms-after-covid-19-a-cross-sectional-study-in-dubai-united-arab-emirates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.48591","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,9]]}}}